We evaluated the expression of HNF4A in liver and pancreatic tissues, and the results showed that compared with the control group, the expression of HNF4A in the NAFLD group showed a significant downward trend (Figure 8). This evidence concerns the gene HNF4A and metabolic dysfunction-associated steatotic liver disease.